{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:53Z","timestamp":1761823553940},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2012.11.091","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T12:43:36Z","timestamp":1366202616000},"page":"B149-B156","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S2","title":["Enabling implementation of the Global Vaccine Action Plan: Developing investment cases to achieve targets for measles and rubella prevention"],"prefix":"10.1016","volume":"31","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Strebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alya","family":"Dabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.11.091_bib0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.091_bib0010","first-page":"15","article-title":"The value of vaccination","volume":"6","author":"Bloom","year":"2005","journal-title":"World Econ"},{"issue":"9570","key":"10.1016\/j.vaccine.2012.11.091_bib0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.091_bib0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vaccine.2010.10.026","article-title":"Economic analysis of the Global Polio Eradication Initiative","volume":"29","author":"Duintjer Tebbens","year":"2011","journal-title":"Vaccine"},{"issue":"27S","key":"10.1016\/j.vaccine.2012.11.091_bib0025","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2009.08.072","article-title":"Financing children's vaccines","author":"Nelson","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.091_bib0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1377\/hlthaff.2011.0381","article-title":"During the \u2018decade of vaccines\u2019 the lives of 6.4 million children valued at $231 billion could be saved","volume":"30","author":"Ozawa","year":"2011","journal-title":"Health Aff"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.091_bib0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1377\/hlthaff.2011.0382","article-title":"Estimated economic benefits during the \u2018decade of vaccines\u2019 include treatment savings, gains in labor productivity","volume":"30","author":"Stack","year":"2011","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0040","series-title":"Global vaccine action plan","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0264-410X(00)00196-1","article-title":"Introducing GAVI and the global fund for children's vaccines","volume":"19","author":"Wittet","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0050","series-title":"Guidelines for preparing proposals for GAVI\/vaccine fund investment. Second draft, version 4","author":"GAVI","year":"2004"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0055","series-title":"GAVI progress report","year":"2011"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0060","series-title":"Disease eradication in the 21st century: implications for global health","first-page":"115","article-title":"Challenges related to the economic evaluation of the direct and indirect benefits and the costs of disease elimination and eradication efforts","author":"Thompson","year":"2011"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0065","series-title":"Disease eradication in the 21st century: implications for global health","first-page":"133","article-title":"Group report: developing an eradication investment case","author":"Thompson","year":"2011"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0070","unstructured":"Thompson KM, Duintjer Tebbens RJ. Development of investment cases for globally-coordinated management of infectious diseases. J Vacc Vaccin, in press."},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.091_bib0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00019053-200927040-00002","article-title":"Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources","volume":"27","author":"Bilcke","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0080","series-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2008"},{"issue":"23","key":"10.1016\/j.vaccine.2012.11.091_bib0085","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3","article-title":"Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective","volume":"18","author":"Edmunds","year":"1999","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.091_bib0090","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1539-6924.2006.00831.x","article-title":"Retrospective cost-effectiveness analyses for polio vaccination in the United States","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Anal"},{"issue":"7","key":"10.1016\/j.vaccine.2012.11.091_bib0095","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of future global policies for managing polioviruses","volume":"98","author":"Thompson","year":"2008","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.091_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/sdr.419","article-title":"Using system dynamics to develop policies that matter: global management of poliomyelitis and beyond","volume":"24","author":"Thompson","year":"2008","journal-title":"Syst Dyn Rev"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0105","series-title":"Global measles and rubella strategic plan, 2012\u20132020","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0110","unstructured":"Thompson KM, Dabbagh A, Strebel PM, Perry R, Gacic-Dobo M, Cochi SL, et al. National and global options for managing the risks of measles and rubella. J Vacc Vaccin, in press."},{"issue":"8","key":"10.1016\/j.vaccine.2012.11.091_bib0115","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson","year":"2008","journal-title":"Medscape J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.091_bib0120","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1287\/mnsc.1080.0965","article-title":"Priority shifting and the dynamics of managing eradicable infectious diseases","volume":"55","author":"Duintjer Tebbens","year":"2009","journal-title":"Manage Sci"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0125","doi-asserted-by":"crossref","unstructured":"Gandhi G, Lydon P, Cornejo S, Brenzel L, Wrobel S, Chang H. Projections of the costs, financing and additional resource requirements for low and lower middle-income country immunization programs over the decade, 2011\u20132020. Vaccine, in press.","DOI":"10.1016\/j.vaccine.2013.01.036"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0130","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/1471-2458-11-739","article-title":"The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases","volume":"11","author":"Fitzpatrick","year":"2011","journal-title":"BMC Public Health"},{"issue":"9387","key":"10.1016\/j.vaccine.2012.11.091_bib0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(03)14337-1","article-title":"Global health goals: lessons from the worldwide effort to eradicate poliomyelitis","volume":"362","author":"Aylward","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0140","first-page":"27","article-title":"Estimating the costs of achieving the WHO\u2013UNICEF Global Immunization Vision and Strategy, 2006\u20132015","volume":"86","author":"Wolfson","year":"2008","journal-title":"Bull WHO"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.091_bib0145","first-page":"1","article-title":"Cost-benefits of measles eradication: effects of a federal intervention","volume":"4","author":"Albritton","year":"1978","journal-title":"Policy Anal"},{"issue":"20","key":"10.1016\/j.vaccine.2012.11.091_bib0150","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0264-410X(98)00125-X","article-title":"A model to estimate the potential economic benefits of measles eradication for the United States","volume":"16","author":"Miller","year":"1998","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.091_bib0155","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/368038","article-title":"Future savings from measles eradication in industrialized countries","volume":"187","author":"Carabin","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.091_bib0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S0950268802008142","article-title":"Economic evaluation of options for measles vaccination strategy in a hypothetical western European country","volume":"130","author":"Beutels","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0165","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/infdis\/jir132","article-title":"Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program","volume":"204","author":"Babigumira","year":"2011","journal-title":"J Infect Dis"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2012.11.091_bib0170","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/S0264-410X(02)00296-7","article-title":"Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis","volume":"20","author":"Acharya","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0175","first-page":"S3","article-title":"Measles eradication versus measles control: an economic analysis","author":"Bishai","year":"2012","journal-title":"J Vacc Vaccin"},{"issue":"S1","key":"10.1016\/j.vaccine.2012.11.091_bib0180","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/jir096","article-title":"Global eradication of measles: an epidemiologic and economic evaluation","volume":"204","author":"Levin","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0185","series-title":"Investing in health for economic development. Report of the Commission on Macroeconomics and Health","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0190","doi-asserted-by":"crossref","first-page":"D91","DOI":"10.1016\/j.vaccine.2011.04.059","article-title":"Measles and rubella eradication in the Americas","volume":"29S","author":"Andrus","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.091_bib0195","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2009-1653","article-title":"Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated","volume":"125","author":"Sugerman","year":"2010","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.vaccine.2012.11.091_bib0200","first-page":"666","article-title":"Measles \u2013 United States, January\u2013May 20, 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.11.091_bib0205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2004-2512","article-title":"The cost of containing one case of measles: the economic impact on the public health infrastructure \u2013 Iowa, 2004","volume":"116","author":"Dayan","year":"2005","journal-title":"Pediatrics"},{"issue":"August (5)","key":"10.1016\/j.vaccine.2012.11.091_bib0210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa060775","article-title":"Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States","volume":"355","author":"Parker","year":"2006","journal-title":"N Engl J Med"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2012.11.091_bib0215","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/infdis\/jir115","article-title":"Health care-associated measles outbreak in the United States after an importation: challenges and economic impact","volume":"203","author":"Chen","year":"2011","journal-title":"J Infect Dis"},{"issue":"S1","key":"10.1016\/j.vaccine.2012.11.091_bib0220","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jir095","article-title":"Strategic planning for measles control: using data to inform optimal vaccination strategies","volume":"204","author":"Simons","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0295","article-title":"Modeling population immunity to support efforts to end human transmission of live polioviruses","author":"Thompson","year":"2012","journal-title":"Risk Analysis"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0230","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.vaccine.2005.12.015","article-title":"Waning antibodies in measles and rubella vaccinees \u2013 a longitudinal study","volume":"24","author":"Kremer","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00006454-199004000-00008","article-title":"Measles, mumps and rubella immunization at nine months in a developing country","volume":"9","author":"Schoub","year":"1990","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.091_bib0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036121","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0245","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vaccine.2003.07.016","article-title":"Herd immunity and herd protection","volume":"22","author":"Paul","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.091_bib0250","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3934\/jimo.2010.6.709","article-title":"A multi-attribute approach for setting pediatric vaccine stockpile levels","volume":"6","author":"Proano","year":"2010","journal-title":"J Ind Manage Optimiz"},{"issue":"34","key":"10.1016\/j.vaccine.2012.11.091_bib0255","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1073\/pnas.1101694108","article-title":"Synthesizing epidemiological and economic optima for control of immunizing infections","volume":"108","author":"Klepac","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.publhealth.27.021405.102248","article-title":"Vaccine shortages: history, impact, and prospects for the future","volume":"27","author":"Hinman","year":"2006","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.091_bib0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for OPV cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0270","first-page":"301","article-title":"Rubella vaccines: WHO position paper. 15 July 2011","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2012.11.091_bib0275","series-title":"Disease eradication in the 21st century: implications for global health","article-title":"Lessons from the late stages of the global polio eradication initiative","author":"Aylward","year":"2011"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.091_bib0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/wber\/lhq018","article-title":"Stop! The polio vaccination cessation game","volume":"24","author":"Barrett","year":"2010","journal-title":"World Bank Econ Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.091_bib0285","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1086\/377694","article-title":"Evolution of measles elimination strategies in the United States","volume":"189","author":"Hinman","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2012.11.091_bib0290","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.inf.0000246840.13477.28","article-title":"The role of measles elimination in development of a National Immunization Program","volume":"25","author":"Orenstein","year":"2006","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12017422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12017422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:26:54Z","timestamp":1539728814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12017422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":58,"alternative-id":["S0264410X12017422"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}